Intravenously administered APAC, a dual AntiPlatelet AntiCoagulant, targets arterial injury site to inhibit platelet thrombus formation and tissue factor activity in mice-Reference-Cited by-同舟云学术

Intravenously administered APAC, a dual AntiPlatelet AntiCoagulant, targets arterial injury site to inhibit platelet thrombus formation and tissue factor activity in mice

Published:2023-08 Issue: Volume:228 Page:163-171
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Bonetti Nicole R.,Jouppila Annukka S.,Saeedi Saravi Seyed Soheil,Cooley Brian C.,Pasterk Lisa,Liberale Luca L.,Gobbato Sara,Lüscher Thomas F.,Camici Giovanni G.,Lassila Riitta P.,Beer Jürg H.

Publisher

Elsevier BV

Subject

Hematology

Reference53 articles.

1. Cardiovascular disease in Europe: epidemiological update 2016;Townsend;Eur. Heart J.,2016

2. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013;Lancet,2015

3. Aging: the next cardiovascular disease?;Camici;Eur. Heart J.,2017

4. Global burden of thrombosis: epidemiologic aspects;Wendelboe;Circ. Res.,2016

5. 2018 ESC/EACTS guidelines on myocardial revascularization;Neumann;EuroIntervention,2019

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment with APAC, a dual antiplatelet anticoagulant heparin proteoglycan mimetic, limits early collar-induced carotid atherosclerotic plaque development in Apoe−/− mice;Atherosclerosis;2024-10

2. Pretreatment with a dual antiplatelet and anticoagulant (APAC) reduces ischemia–reperfusion injury in a mouse model of temporary middle cerebral artery occlusion—implications for neurovascular procedures;Acta Neurochirurgica;2024-03-15